The aim of the study is to investigate if P6 acupuncture made after induction of general anaesthesia might be effective for the prevention of PONV as ondansetron and if the acupuncture-ondansetron combination could enhance single therapy efficacy in patients undergoing laparoscopic cholecystectomy...
Date First Received: May 5, 2008
Last Updated: May 7, 2008
Verified by: Catholic University of the Sacred Heart, May 2008
Clinical Trial Phase: Phase 4 | Start Date: January 2006
Overall Status: Completed
Estimated Enrollment: 140
Brief Summary
Condition Keyword(s):
The aim of the study is to investigate if P6 acupuncture made after induction of general anaesthesia might be effective for the prevention of PONV as ondansetron and if the acupuncture-ondansetron combination could enhance single therapy efficacy in patients undergoing laparoscopic cholecystectomy.
Study Type: Interventional
Study Design: Prevention, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Parallel Assignment
Study Primary Completion Date: September 2007
Intervention(s) in this Clinical Trial
- Other: Acupuncture
- Drug: Ondansetron
- Drug: Physiological saline solution
- Other: Sham acupuncture
- Drug: Ondansetron
- Other: Acupuncture at P6 point
- Drug: Physiological saline solution
- Other: Sham acupuncture
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: A
- Patients receiving acupuncture at P6 point plus physiological saline solution
- Active Comparator: B
- Patients receiving ondansetron plus sham acupuncture
- Other: C
- Patients receiving ondansetron plus acupuncture at P6 point
- Placebo Comparator: D
- Patients receiving physiological saline solution plus sham acupuncture
Outcome Measures for this Clinical Trial
Primary Measures
- postoperative nausea and vomiting
- Time Frame: 24 postoperative hours
Safety Issue?: No
- Time Frame: 24 postoperative hours
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients ASA I-II scheduled for elective laparoscopic cholecystectomy.
Exclusion Criteria:
- Patient's refusal
- Patients with history of carpal tunnel syndrome or eczema at P6 point
- Pregnant patients
- Female patients in a phase of the menstrual cycle other than premenstrual, nausea and vomiting within 24 hours before anaesthesia
- Known allergy to anti-inflammatory drugs, opioids and ondansetron.
- Patients with a pre-existing chronic pain disorder or with a gastrointestinal disease.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 70 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Catholic University of the Sacred Heart
Overall Clinical Trial Officials and Contacts
Germano De Cosmo, MD Principal Investigator Catholic University of Sacred Heart
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00674713
Study ID Number: 1014/05
ClinicalTrials.gov Identifier: NCT00674713
Health Authority: Italy: Ethics Committee
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.